71 West Capital Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
8,496
+2,542
+43% +$138K 0.01% 289
2026
Q1
$374K Buy
5,954
+1,197
+25% +$95.8K 0.02% 209
2025
Q4
$454K Buy
+4,757
New +$466K 0.02% 152

Other funds holding BSX

71 West Capital Partners's BSX Position: Q2 2026 in Review

71 West Capital Partners increased its Boston Scientific (BSX) stake by 43% in Q2 2026, buying an estimated $138K and bringing the position to 8,496 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #289.

71 West Capital Partners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $454K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • 71 West Capital Partners held 8,496 shares of Boston Scientific worth $363K as of Q2 2026.
  • 71 West Capital Partners bought 2,542 Boston Scientific shares in Q2 2026, an estimated $138K.
  • Boston Scientific made up 0.01% of 71 West Capital Partners's portfolio in Q2 2026, its #289 holding.
  • 71 West Capital Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 71 West Capital Partners's Boston Scientific position peaked at $454K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.